Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / ultragenyx reports serious adverse effects in gene t


RARE - Ultragenyx reports serious adverse effects in gene therapy trial

2024-04-15 09:42:46 ET

Shares of Ultragenyx Pharmaceutical ( NASDAQ: RARE ) plunged as much as 7% on Monday after the company reported serious adverse effects in a gene therapy trial evaluating its investigational drug candidate, GTX-102, in patients with Angelman syndrome....

For further details see:

Ultragenyx reports serious adverse effects in gene therapy trial
Stock Information

Company Name: Ultragenyx Pharmaceutical Inc.
Stock Symbol: RARE
Market: NASDAQ
Website: ultragenyx.com

Menu

RARE RARE Quote RARE Short RARE News RARE Articles RARE Message Board
Get RARE Alerts

News, Short Squeeze, Breakout and More Instantly...